On September 14, 2023, the Federal Trade Commission (FTC) issued a statement condemning pharmaceutical manufacturers’ improper inclusion of patents in the Food and Drug Administration’s (FDA’s) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback